Swiss National Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-63,100
| Closed | -$20M | – | 2544 |
|
|
2023
Q4 | $20M | Sell |
63,100
-6,900
| -10% | -$2.18M | 0.01% | 626 |
|
|
2023
Q3 | $11.8M | Buy |
70,000
+4,900
| +8% | +$829K | 0.01% | 803 |
|
|
2023
Q2 | $14.1M | Buy |
65,100
+5,700
| +10% | +$1.24M | 0.01% | 750 |
|
|
2023
Q1 | $10.8M | Sell |
59,400
-5,200
| -8% | -$945K | 0.01% | 837 |
|
|
2022
Q4 | $12.7M | Buy |
64,600
+1,300
| +2% | +$255K | 0.01% | 801 |
|
|
2022
Q3 | $14.2M | Buy |
63,300
+10,700
| +20% | +$2.41M | 0.01% | 721 |
|
|
2022
Q2 | $6.65M | Buy |
52,600
+3,500
| +7% | +$443K | ﹤0.01% | 1146 |
|
|
2022
Q1 | $6.23M | Buy |
49,100
+3,700
| +8% | +$469K | ﹤0.01% | 1311 |
|
|
2021
Q4 | $5.95M | Sell |
45,400
-100
| -0.2% | -$13.1K | ﹤0.01% | 1345 |
|
|
2021
Q3 | $5.57M | Buy |
45,500
+3,800
| +9% | +$465K | ﹤0.01% | 1382 |
|
|
2021
Q2 | $4.75M | Buy |
41,700
+14,100
| +51% | +$1.61M | ﹤0.01% | 1531 |
|
|
2021
Q1 | $3.32M | Buy |
27,600
+500
| +2% | +$60.1K | ﹤0.01% | 1699 |
|
|
2020
Q4 | $2.75M | Buy |
27,100
+400
| +1% | +$40.6K | ﹤0.01% | 1728 |
|
|
2020
Q3 | $2.06M | Buy |
26,700
+500
| +2% | +$38.7K | ﹤0.01% | 1704 |
|
|
2020
Q2 | $2.92M | Buy |
+26,200
| New | +$2.92M | ﹤0.01% | 1489 |
|